Cufsniff LR Syrup combines Levocloperastine 20mg/5ml, an advanced antitussive, with Chlorpheniramine Maleate 4mg/5ml, a proven anti-allergic agent. This dual-action formulation effectively suppresses cough, reduces throat irritation, and controls allergic symptoms associated with upper respiratory tract infections, seasonal allergies, and chronic cough.
Levocloperastine helps provide controlled cough suppression without causing excessive drowsiness, while Chlorpheniramine reduces allergic triggers such as sneezing, nasal irritation, and post-nasal drip. This combination offers comprehensive respiratory relief, making it an ideal choice for both adults and pediatric patients under medical supervision.
For distributors and resellers, Cufsniff LR Syrup is a high-demand respiratory-care product, widely prescribed in ENT clinics, pediatric departments, general OPDs, and hospitals. Seasonal spikes, recurrent respiratory infections, and rising pollution levels ensure year-round movement and strong market needs.
Adding Cufsniff LR Syrup to your product range enhances your respiratory and ENT-care segment, unlocking opportunities for pharmacy distribution, hospital supplies, institutional orders, tender submissions, export channels, and third-party manufacturing. Its broad efficacy and high prescription rate make it a valuable and profitable addition for pharmaceutical distributors.